--- a
+++ b/clusters/3009knumclusters/clust_15.txt
@@ -0,0 +1,136 @@
+Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 ml/min/1.73 m^2 or a serum creatinine based on age/gender as follows:\r\n* Age 1 to < 2 years: maximum serum creatinine (mg/dL) 0.6 for males and females\r\n* Age 2 to < 6 years: 0.8 for males and females\r\n* Age 6 to < 10 years: 1 for males and females\r\n* Age 10 to < 13 years: 1.2 for males and females\r\n* Age 13 to < 16 years: 1.5 for males and 1.4 for females\r\n* Age >= 16 years: 1.7 for males and 1.4 for females
+Participants must be skeletally mature defined as females with a bone age >= 15 years and males with a bone age >= 17 years
+Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows:\r\n* Age < 6 months: Maximum serum creatinine (mg/dL): 0.4 for males and females\r\n* Age 6 months to < 1 year: Maximum serum creatinine (mg/dL): 0.5 for males and females\r\n* Age 1 to < 2 years: Maximum serum creatinine (mg/dL): 0.6 for males and females\r\n* Age 2 to < 6 years: Maximum serum creatinine (mg/dL): 0.8 for males and females\r\n* Age 6 to < 10 years: Maximum serum creatinine (mg/dL): 1 for males and females\r\n* Age 10 to < 13 years: Maximum serum creatinine (mg/dL): 1.2 for males and females\r\n* Age 13 to < 16 years: Maximum serum creatinine (mg/dL): 1.5 for males and 1.4 for females\r\n* Age >= 16 years: Maximum serum creatinine (mg/dL): 1.7 for males and 1.4 for females
+Males or females age greater than or equal to 18 years at the time of informed consent
+Males or females who are 18 years or older
+Males and females of any age
+Males or females, ?18 years of age
+Males or females age ? 18 years at the time of informed consent
+Males and Females at least 18 years of age
+Since the teratogenic potential of this combination is currently unknown, females who are pregnant or lactating are excluded. Males and females should perform abstinence or use barrier to prevent pregnancy.
+Males or non-pregnant, non-lactating females, ? 18 years of age
+Adult males or females aged 18 years or over
+Males and females ? 18 years of age at screening
+Females age ? 18 years old
+Are males or females aged ? 18 years
+Males and females 12 years old or older
+Males and females ? 18 years of age.
+Males and females 18 years old or older.
+Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73^2 or serum creatinine based on age/gender as follows:\r\n* Age 1 month to < 6 months: 0.4 for males and 0.4 for females\r\n* Age 6 months to < 1 year: 0.5 for males and 0.5 for females\r\n* Age 1 to < 2 years: 0.6 for males and 0.6 for females\r\n* Age 2 to < 6 years: 0.8 for males and 0.8 for females\r\n* Age 6 to < 10 years: 1 for males and 1 for females\r\n* Age 10 to < 13 years: 1.2 for males and 1.2 for females\r\n* Age 13 to < 16 years: 1.5 for males and 1.4 for females\r\n* Age >= 16 years: 1.7 for males and 1.4 for females\r\n** Participants with urinary tract obstruction by tumor must meet the renal function criteria listed above AND must have unimpeded urinary flow established via decompression of the obstructed portion of the urinary tract
+Males ?18 years of age at the time of signing consent
+STRATUM C: Participant must be skeletally mature as defined as females with a bone age > 15 years and males with a bone age > 17 years
+Males or females ?18 years of age.
+Males ? 18 years of age on the day of consenting to the study.
+Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 ml/min/1.73 m^2 or a serum creatinine based on age/gender as follows:\r\n* 1 to < 2 years: 0.6 mg/dL for males and females\r\n* 2 to < 6 years: 0.8 mg/dL for males and females\r\n* 6 to < 10 years: 1.0 mg/dL for males and females\r\n* 10 to < 13 years: 1.2 mg/dL for males and females\r\n* 13 to < 16 years: 1.5 mg/dL for males and 1.4 mg/dL for females\r\n* > = 16 years: 1.7 mg/dL for males and 1.4 mg/dL for females
+Males and females not willing to use effective contraception.
+Males and Females, age ? 18 years old
+Males and Females, age ? 18 years old
+Refusal to use adequate contraception for fertile patients (females and males)
+Males or females aged ? 20 years and < 75 years
+Males and females >=18 years of age (at the time consent is obtained)
+Males and females ? 18 years of age
+Males and females ? 18 years of age
+Documented adequate hematocrit > 35% for males and 33% for females
+Normal creatinine phosphokinase (CPK) defined as not exceeding maximum value listed below :\r\n* Age: 0 to < 4 years; 305 units/L for males and 305 units/L for females\r\n* Age: 4 to < 7 years; 230 units/L for males and 230 units/L for females\r\n* Age: 7 to < 10 years; 365 units/L for males and 365 units/L for females\r\n* Age: 10 to < 12 years; 215 units/L for males and 230 units/L for females\r\n* Age: 12 to < 14 years; 330 units/L for males and 295 units/L for females\r\n* Age: 14 to < 16 years; 335 units/L for males and 240 units/L for females\r\n* Age: 16 to < 19 years; 370 units/L for males and 230 units/L for females\r\n* Age: >= 19 years; 170 units/L for males and 145 units/L for females
+Serum creatinine < 2 x upper limit of normal (ULN) for age\r\n1 to < 2 yrs males: 0.6 females: 0.6\r\n2 to < 6 yrs males: 0.8 females: 0.8\r\n6 to < 10 yrs males: 1 females: 1\r\n10 to < 13 yrs males: 1.2 females: 1.2\r\n13 to < 16 yrs males: 1.5 females: 1.4\r\n17 to 20 yrs males: 1.7 females: 1.4\r\nOver 21 yrs males: 2 x ULN females: 2 x ULN
+Males and females at least 18 years of age.
+Patients must have adequate renal function defined as: creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 ml/min/1.73 m^2 or a serum creatinine based on age/gender less than listed value: 1 to < 2 years 0.6 mg/dL for both males and females, 2 to < 6 years 0.8 mg/dL for both males and females, 6 to < 10 years 1 mg/dL for both males and females, 10 to < 13 years 1.2 mg/dL for both males and females, 13 to < 16 years 1.5 mg/dL for males and 1.4 mg/dL for females, >= 16 years 1.7 for males and 1.4 for females
+COHORTS 1 AND 2: HEALTHY VOLUNTEERS: Males and females aged 18-50 years
+Age 18 years or older, males and females.
+Males or females 21 years or older
+Criteria 2 Males or females ? 18 years of age
+Males or non-pregnant, non-breastfeeding females 18 years-of-age or older
+Males or non-pregnant, non-breastfeeding females 18 years-of-age or older
+Males and females, age ?18 and ? 65 years of age
+Males and females, age ?18 and ? 75 years of age
+Males or females ? 18 years of age at screening.
+Males or females at least 18 years of age
+Males or females aged ?18 years at screening.
+Males and females ? 18 years of age
+Creatinine clearance or radioisotope GFR (glomerular filtration rate) >= 70 mL/min/1.73 m^2 or a serum creatinine based on age/gender less than the listed value in the table below: \r\n* 1 to < 2 years 0.6 mg/dL for both males and females, \r\n* 2 to < 6 years 0.8 mg/dL for both males and females, \r\n* 6 to < 10 years 1.0 mg/dL for both males and females
+Males >=18 years of age (at the time written consent is obtained for screening)
+-  Males and females at least 18 years of age
+Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2, or a serum creatinine based on age/gender as follows:\r\n* Age < 6 months; maximum serum creatinine (mg/dL): 0.4 for males and females\r\n* Age 6 months to < 1 year; maximum serum creatinine (mg/dL): 0.5 for males and females\r\n* Age 1 to < 2 years; maximum serum creatinine (mg/dL): 0.6 for males and females\r\n* Age 2 to < 6 years; maximum serum creatinine (mg/dL): 0.8 for males and females\r\n* Age 6 to < 10 years; maximum serum creatinine (mg/dL): 1 for males and females\r\n* Age 10 to < 13 years; maximum serum creatinine (mg/dL): 1.2 for males and females\r\n* Age 13 to < 16 years; maximum serum creatinine (mg/dL): 1.5 for males and 1.4 for females\r\n* Age >= 16 years; maximum serum creatinine (mg/dL): 1.7 for males and 1.4 for females
+Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 ml/min/1.73 m^2 or a serum creatinine based on age/gender as follows:\r\n* Age 1 to < 2 years: maximum serum creatinine (mg/dL): 0.6 for males and 0.6 for females\r\n* Age 2 to < 6 years: maximum serum creatinine (mg/dL): 0.8 for males and 0.8 for females\r\n* Age 6 to < 10 years: maximum serum creatinine (mg/dL): 1 for males and 1 for females\r\n* Age 10 to < 13 years: maximum serum creatinine (mg/dL): 1.2 for males and 1.2 for females\r\n* Age 13 to < 16 years: maximum serum creatinine (mg/dL): 1.5 for males and 1.4 for females\r\n* Age >= 16 years: maximum serum creatinine (mg/dL): 1.7 for males and 1.4 for females
+Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 ml/min/1.73 m^2 or a maximum serum creatinine (mg/dL) based on age/gender as follows:\r\n* 1 to < 2 years: 0.6 \r\n* 2 to < 6 years: 0.8 \r\n* 6 to < 10 years: 1 \r\n* 10 to < 13 years: 1.2 \r\n* 13 to < 16 years: 1.5 for males, 1.4 for females\r\n* >= 16 years: 1.7 for males, 1.4 for females
+-  Males and females ? 18 years of age
+Female subjects age >= 18 years (males with breast cancer are eligible)
+Males or females aged 18 years or older
+Males and females at least 18 years of age at the time of signing of the informed consent document.
+Patients must be males ? 18 years of age
+Males and females aged >=18 years (for Japan only: Age >=20 years at time of signing Informed Consent Form) with histologically confirmed metastatic colorectal cancer (mCRC).
+A serum creatinine =< upper limit of normal (ULN) based on age/gender as follows:\r\n* Age 1 month to < 6 months: 0.4 for males, 0.4 for females\r\n* Age 6 months to < 1 year: 0.5 for males, 0.5 for females\r\n* Age 1 to < 2 years: 0.6 for males, 0.6 for females\r\n* Age 2 to < 6 years: 0.8 for males, 0.8 for females\r\n* Age 6 to < 10 years: 1 for males, 1 for females\r\n* Age 10 to < 13 years: 1.2 for males, 1.2 for females\r\n* Age 13 to < 16 years: 1.5 for males, 1.4 for females\r\n* Age >= 16 years: 1.7 for males, 1.4 for females
+Males or females aged at least 18 years (or any age greater than 18 years as determined by country legislation) at the time of informed consent
+Males and females 18 years old and greater
+Males or non-pregnant, non-breastfeeding females 18 years-of-age or older.
+Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 ml/min/1.73 m^2 or a serum creatinine based on age/gender less than listed value in the table below: 1 to < 2 years 0.6 mg/dL for both males and females, 2 to < 6 years 0.8 mg/dL for both males and females, 6 to < 10 years 1 mg/dL for both males and females, 10 to < 13 years 1.2 mg/dL for both males and females, 13 to < 16 years 1.5 mg/dL for males and 1.4 mg/dL for females, >= 16 years 1.7 for males and 1.4 for females
+Males and females ? 18 years old
+Females who are pregnant or breastfeeding, and males and females who cannot comply with requirements to avoid fathering a child or becoming pregnant
+Males or females aged at least 18 years (or any age greater than 18 years as determined by country legislation) at the time of informed consent (Screen 1).
+Males and females aged ?18 years;
+Males and females age ?18 years
+Males and females ? 18 years of age
+Males and females ? 18 years of age;
+Males or females ? 18 years of age
+DONOR: Hematocrit > 35% for males and 33% for females
+Males and females ?18 years of age
+Subjects must be males or females age 18 years or older.
+Glomerular filtration rate >= 60 cc/min/1.73 m^2 or serum creatinine based on age as follows:\r\n* 1 to 2 years: 0.6 mg/dL for males and females\r\n* 2 to 6 years: 0.8 mg/dL for males and females\r\n* 6 to 10 years: 1 mg/dL for males and females\r\n* 10 to < 13 years: 1.2 mg/dL for males and females\r\n* 13 to 16 years: 1.5 mg/dL for males and 1.4 mg/dL for females\r\n* > 16 years: 1.7 mg/dL for males and 1.4 mg/dL for females
+Males and females age ? 18 yrs;
+Males and females >=18 years of age (at the time consent is obtained).
+Males and females ?18 years of age for NSCLC, TNBC, and CRPC
+Males and females ?16 years of age for NMC
+Males 18 years of age and above
+Males or non-pregnant, non-breastfeeding females 18 years-of-age or older.
+Males and females ? 18 years of age at the time of signing the informed consent document (ICD).
+Males or females
+Males and females ?18 years of age at the time of signing the consent form.
+Males and females >=18 years of age (at the time consent is obtained).
+Males or females aged 18 or older
+Males or females, age 18 years or older.
+Females or males, aged >=18 years at the time of signing the informed consent form (ICF).
+Males and females ?18 years of age (at the time consent is obtained);
+Males and postmenopausal females, 18 years or older
+Glomerular filtration rate >= 60 cc/min/1.73 m^2, or serum creatinine based on age as follows:\r\n* Age 1 to 2 years: 0.6 for males and 0.6 for females\r\n* Age 2 to 6 years: 0.8 for males and 0.8 for females\r\n* Age 6 to 10 years: 1 for males and 1 for females\r\n* Age 10 to < 13 years: 1.2 for males and 1.2 for females\r\n* Age 13 to 16 years: 1.5 for males and 1.4 for females\r\n* Age > 16 years: 1.7 for males and 1.4 for females
+Males and females ? 18 years of age.
+Males or females of any race at least 18 years of age
+Males age ? 18 years
+Skeletally mature adult males and females 18 years of age or older.
+Males or females at least 18 years of age
+Males and females ? 18 years of age
+Males and females >=18 years of age (at the time consent is obtained).
+Males or non-pregnant, non-breastfeeding females 18 years-of-age or older.
+Males and non-pregnant, non-lactating females, 18 years of age or older
+Males and females ? 18 years of age
+Males and females >= 18 years of age
+Males and females 18 years of age and older at the time of screening
+Males / females, ? 18 years old, any race / ethnicity, who can provide written Informed Consent
+Males and females ? 18 years of age
+5. Fertile males and females must agree to the use of an adequate form of contraception, e.g., condoms for males.
+Males or non-pregnant, non-breastfeeding females 18 years-of-age or older with histologically confirmed non-Hodgkins lymphoma, without known or clinically suspected CNS involvement, that is refractory to available therapy or for which there is no available therapy.
+Males >=18 years of age (at the time consent is obtained)
+Males and females of any age
+Males and females greater than or equal to 18 years of age
+Males and females ? 18 years of age.
+Age greater than or equal to (>=) 18 years, including males and females;
+Males or females aged greater than or equal to 18 years at the time of informed consent.
+Males ? 18 years of age
+Females at least 18 years old;
+Males are not permitted to participate
+Males or females age ?18 years at the time of informed consent form (ICF)
+Males and females of 18 to 89 years of age.
+Males and Females, ages 18 and older
+Pregnancy or failure to use effective contraception in fertile males or females, and breast-feeding females
+Males age ? 18 years
+Males or females aged ?18 years on day of consent.
+Males will be excluded.
+Males or females aged 18 years or older
+Males or females, aged between 50 and 75.
+Males and females must weigh >= 40 Kg
+Males and females,age 1 year(365 days) to < 18 (17 years and 364 days) years.
+Males and females aged ? 1.0 year and < 66.0 years
+2. Males or females aged ?18 years;
+Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 ml/min/1.73 m^2 or a serum creatinine based on age/gender as follows: NOTE: for MRI imaging serum creatinine measurement must meet the same criteria and be measured within 1 week of the imaging session\r\n* Age 1 month to < 6 months: 0.4 for males; 0.4 for females\r\n* Age 6 months to < 1 year: 0.5 for males; 0.5 for females\r\n* Age 1 to < 2 years: 0.6 for males; 0.6 for females\r\n* Age 2 to < 6 years: 0.8 for males; 0.8 for females\r\n* Age 6 to < 10 years: 1.0 for males; 1.0 for females\r\n* Age 10 to < 13 years: 1.2 for males; 1.2 for females\r\n* Age 13 to < 16 years: 1.5 for males; 1.4 for females\r\n* Age >= 16 years: 1.7 for males; 1.4 for females
+Females ? 21 years of age presenting for routine cervical cancer screening.
+Males and females of age ? 18 years or of age ? 22 years for those assigned to Optune™ at the time of signing of the informed consent document.
+Males or females age ?18 years at the time of informed consent.